Novartis to pay $678m to resolve legacy litigation with US authorities
Novartis has reached a settlement with the US Attorney’s Office for the Southern District of New York, the…
Janssen secures EC approval for preventive Ebola vaccine
02 Jul 20The Ebola vaccine regimen has been developed by leveraging Janssen’s AdVac technology, and Bavarian Nordic’s MVA-BN technology
US FDA approves BAVENCIO to treat urinary bladder cancer
01 Jul 20BAVENCIO is a human anti-programmed death ligand-1 (PD-L1) antibody, co-developed and co-commercialised by Pfizer and EMD Serono
INOVIO releases positive results from Phase 1 trial of Covid-19 vaccine
01 Jul 20INO-4800 is a DNA vaccine candidate being developed to protect against the novel coronavirus SARS-CoV-2, which causes Covid-19
GSK’s Duvroq approved in Japan for anaemia related to chronic kidney disease
30 Jun 20Duvroq has been designed to provide an orally-convenient treatment option, avoid administration challenges and need for cold storage…
Roche gets FDA approval for Phesgo to treat HER2-positive breast cancer
30 Jun 20Phesgo offers faster administration of Perjeta and Herceptin under the skin in just minutes, compared to hours with…
Carlyle Group to acquire 20% stake in Piramal Pharma for $490m
29 Jun 20Piramal Pharma includes Piramal Pharma Solutions, an end-to-end contract development and manufacturing (CDMO) business, Piramal Critical Care, a…
Bristol Myers Squibb secures EC approval for Reblozyl to treat anaemia
29 Jun 20Reblozyl is an erythroid maturation agent that regulates late-stage red blood cell (RBC) maturation to reduce or prevent…
Novartis reaches $347m settlement with DOJ and SEC over FCPA investigations
26 Jun 20Novartis, along with certain of its subsidiaries, has agreed to pay $233.9m to the DOJ and $112.8m to…
Hansa Biopharma granted positive CHMP opinion for Idefirix for kidney transplant
26 Jun 20The European Medicines Agency has accepted the company’s application for review of the marketing authorisation of imlifidase in…